Effects of Intradermal Therapy (Mesotherapy) on Bilateral Cervicobrachial Pain

Ranieri, Maurizio; Marvulli, Riccardo; D’Alesio, Eleonora; Riccardi, Mariagrazia; Raele, Maria Vittoria; Dell’Anna, Laura; Fai, Annatonia; Farì, Giacomo; Megna, Marisa

doi:10.3390/jpm14010122

Cited by 3 publications

(3 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Another study published in January 2024 by Ranieri et al [ 27 ] reported on the use of mesotherapy for cervicobrachial pain syndrome with bilateral radiating to the arms/shoulders. This study found that mesotherapy with diclofenac sodium reduced pain intensity and improved functional outcomes, with no significant side effects in patients with myofascial pain syndrome located in the cervical/shoulder region.…”

Section: Discussionmentioning

confidence: 99%

The Role of Rehabilitation after Spinal Mesotherapy in a Three-Stage Treatment Concept

Koszela,

Słupiński,

Woldańska-Okońska

2024

JCM

View full text Add to dashboard Cite

Sedentary lifestyles, work overload, and lack of regular physical activity are risk factors for spinal pain syndrome. In everyday medical practice, spinal pain syndrome of a muscular or myofascial, or non-neurogenic, nature is diagnosed. This problem affects a large group of patients and reaches about 70–80% of spinal pain cases. Usually, one of the primary treatments is with NSAIDs (Non-steroidal Anti-Inflammatory Drugs). In this case, one treatment method that is safe and has no side effects is spinal mesotherapy. This method consists of performing multi-point intradermal microinjections with the administration of drugs or medical devices. Based on a new perspective on the treatment of spinal pathology—the so-called three-stage treatment concept—it is necessary to deal with the risk factor(s) of spinal pain syndrome and reduce or at least modify them (stage I). This is followed by a broadly understood medical therapy, in this case spinal mesotherapy (stage II), which aims to relax tense tissues, improve mobility in the spine and thus reduce pain. As a result, conditions are created for the necessary process, which is rehabilitation in the broadest sense (stage III). Movement therapy, which is crucial in spinal pain syndrome, is performed with less pain, after obtaining better patient mobility. The purpose of this article is to evaluate the role of rehabilitation of patients after spinal mesotherapy in terms of the three-stage treatment concept for spinal pathology.

show abstract

Section: Discussionmentioning

confidence: 99%

The Role of Rehabilitation after Spinal Mesotherapy in a Three-Stage Treatment Concept

Koszela,

Słupiński,

Woldańska-Okońska

2024

JCM

View full text Add to dashboard Cite

show abstract

“…Using this equipment, the biomechanical feature of the BB is calculated as a numerical value considering the vibration reduced by the muscle . The accurateness of this measurement is well-documented in the literature [ 29 ].…”

Section: Case Reportmentioning

confidence: 99%

The Effectiveness of Combining Botulinum Toxin Type A and Therapeutic Exercise in Treating Spasticity in a Patient with Complicated Stiff-Person Syndrome: A Case Report

Marvulli,

Raele,

Riccardi

et al. 2024

Diseases

Self Cite

View full text Add to dashboard Cite

Stiff-person syndrome is rare and disabling autoimmune condition that most frequently affects women, with no real predisposition by race. Diagnosis is often arduous, which is why patients concomitantly suffer from anxiety and depression. To date, drug therapy is based on the use of benzodiazepines, barbiturates, and baclofen. Refractory cases are treated with intravenous immunoglobulin, plasmapheresis, B lymphocyte depletion with rituximab, and even the implantation of intrathecal baclofen devices. Botulinum toxin injection is frequently used, even if it still has an unclear role in the literature. Our case report aims to demonstrate the efficacy of a combined treatment of botulinum toxin and therapeutic exercise in a 65-year-old patient with biceps brachii muscle hypertonia and diffuse spasms of the axial musculature, using rating scales such as the Numeric Rating Scale (NRS) and Modified Ashworth Scale (MAS), joint range of motion (ROM) measurement, and muscle dynamic stiffness mensuration, which is performed by using the MyotonPro®. All the assessments were conducted at the first evaluation (T0), soon after the combined treatment with botulin toxin and therapeutic exercise (T1), three months (T2), six months (T3), and eight months after the botulinum toxin injection (T4). The patient demonstrated benefits for more than 6 months with no side effects. The combined therapy of botulinum toxin and therapeutic exercise had an excellent result in our patient.

show abstract

“…Analgesic mesotherapy is an outpatient treatment involving multiple mesodermal microinjections of active substances, administered through 27G 0.4 × 4 mm needles, at body parts affected by pain and functional limitation. This technique allows a small amount of drug to be used directly on the area to be treated, reducing systemic drug intake ( 25 , 26 ).…”

Section: Introductionmentioning

confidence: 99%

Extracorporeal ShockWave Treatment vs. mesotherapy in the treatment of myofascial syndromes: a clinical trial

Scaturro,

Migliorino,

Lauricella

et al. 2024

Front. Med.

View full text Add to dashboard Cite

Numerous scientific papers have compared different treatment options in the management of myofascial pain syndrome. This study evaluated the efficacy of Extracorporeal ShockWave Treatment (ESWT) and mesotherapy in patients with Myofascial Pain Syndrome (MPS) in terms of improvement in pain, functional capacity, and quality of life. A case–control study was conducted on 54 patients, who were randomized into 2 groups: group A, consisting of 27 patients, who were treated with 5 sessions of focal ESWT on a weekly basis; and group B, consisting of 27 patients, who underwent 5 sessions of mesotherapy with Thiocolchicoside fl 4 mg/2 mL and Mepivacaine fl 10 mg/1 mL on a weekly basis. Patients were evaluated at enrollment (T0), after 5 weeks, at the end of rehabilitation treatment (T1), and at a follow- up 30 days after the end of treatment (T2), by administering rating scales (Numeric Rating Scale (NRS) - Pressure Pain Threshold (PPT) – Short Form-36 (SF-36)). The results showed that focal ESWT and Mesoterapy are two valid and effective treatment options in reducing algic symptoms and improving short- and long-term quality of life. However, the use of ESWTs, despite being mildly painful but tolerated, has been shown to be superior to mesotherapy in terms of pain reduction and increased functional capacity.

show abstract

Effects of Intradermal Therapy (Mesotherapy) on Bilateral Cervicobrachial Pain

Cited by 3 publications

References 34 publications

The Role of Rehabilitation after Spinal Mesotherapy in a Three-Stage Treatment Concept

The Role of Rehabilitation after Spinal Mesotherapy in a Three-Stage Treatment Concept

The Effectiveness of Combining Botulinum Toxin Type A and Therapeutic Exercise in Treating Spasticity in a Patient with Complicated Stiff-Person Syndrome: A Case Report

Extracorporeal ShockWave Treatment vs. mesotherapy in the treatment of myofascial syndromes: a clinical trial

Contact Info

Product

Resources

About